{
    "hands_on_practices": [
        {
            "introduction": "The reliability of any immunophenotyping result begins with the quality of the assay itself. Before we can interpret complex patterns, we must be confident that our tools can clearly distinguish a true signal from background noise. This practice focuses on quantifying assay performance by calculating a resolution metric, often called a stain index, which is a crucial measure of signal-to-noise that determines our ability to reliably detect both bright and diagnostically critical dim antigens. ",
            "id": "5226068",
            "problem": "A clinical flow cytometry laboratory is validating an antibody for immunophenotyping in Chronic Lymphocytic Leukemia (CLL). The laboratory acquires two populations in a single assay: a negative reference population lacking the target antigen and a positive population expressing the antigen. Assume each population’s fluorescence intensity distribution is approximately Gaussian, and that the variability relevant for distinguishing dim targets is dominated by the dispersion of the negative population. The laboratory measures the Mean Fluorescence Intensity (MFI) of the positive population as $12{,}000$ and the MFI of the negative population as $1{,}000$. The standard deviation of the negative population’s fluorescence is measured as $300$.\n\nStarting from the definition of a Gaussian distribution and the standard deviation as a dispersion measure, construct a dimensionless resolution metric that expresses the separation of the positive and negative means in units of twice the dispersion of the negative population, and then compute its value using the provided measurements. State your final numeric result rounded to four significant figures. Express the index as a dimensionless number. In your reasoning, briefly comment on whether the resulting value would be considered suitable for detecting a dim antigen in immunophenotyping of leukemias and lymphomas, based on widely used laboratory practice.",
            "solution": "The problem is subjected to validation and is deemed valid. It is scientifically grounded in the principles of flow cytometry and statistical analysis of measurement data. The problem is well-posed, objective, and contains all necessary information to construct the required metric and compute its value. It is directly relevant to the specified field of laboratory diagnostics and the topic of immunophenotyping.\n\nThe problem requires the construction of a dimensionless resolution metric based on the principles of Gaussian distributions. The fluorescence intensity ($I$) of a cell population is assumed to follow a Gaussian (or normal) distribution, which is characterized by a mean ($\\mu$) and a standard deviation ($\\sigma$). The probability density function is given by:\n$$f(I; \\mu, \\sigma) = \\frac{1}{\\sigma\\sqrt{2\\pi}} \\exp\\left(-\\frac{(I-\\mu)^2}{2\\sigma^2}\\right)$$\nHere, $\\mu$ represents the Mean Fluorescence Intensity (MFI), and $\\sigma$ represents the dispersion or spread of the population's fluorescence.\n\nWe are given two populations: a positive population with mean $MFI_{pos}$ and a negative population with mean $MFI_{neg}$ and standard deviation $\\sigma_{neg}$.\nThe givens are:\n$MFI_{pos} = 12,000$\n$MFI_{neg} = 1,000$\n$\\sigma_{neg} = 300$\n\nThe separation between the centers of the two distributions is the difference between their means:\n$$ \\text{Separation} = MFI_{pos} - MFI_{neg} $$\nThis quantity has units of fluorescence intensity.\n\nThe problem specifies that the resolution should be expressed in units of \"twice the dispersion of the negative population\". The dispersion is given by the standard deviation, $\\sigma_{neg}$. Therefore, the unit of measure for our comparison is $2\\sigma_{neg}$.\n\nTo create a dimensionless metric, we form a ratio of the separation to this unit of measure. Let us denote this resolution metric by $R$. Following the problem's definition:\n$$ R = \\frac{\\text{Separation}}{\\text{Unit of Measure}} = \\frac{MFI_{pos} - MFI_{neg}}{2 \\sigma_{neg}} $$\nThis metric quantifies how many \"units\" of $2\\sigma_{neg}$ fit into the distance between the two population means. This is a measure of signal-to-noise, where the signal is the separation of the positive from the negative population, and the noise is defined by the spread of the negative population. This metric is functionally equivalent to the commonly used \"Separation Index\" in flow cytometry.\n\nNow, we compute the value of $R$ using the provided data:\n$$ R = \\frac{12,000 - 1,000}{2 \\times 300} $$\n$$ R = \\frac{11,000}{600} $$\n$$ R = \\frac{110}{6} = \\frac{55}{3} $$\nAs a decimal, this is $R \\approx 18.3333...$. Rounding to four significant figures, as requested, we get:\n$$ R \\approx 18.33 $$\n\nRegarding the suitability of this value for immunophenotyping of leukemias and lymphomas, a resolution metric of $18.33$ is considered excellent. In clinical diagnostics, clear separation between antigen-positive and antigen-negative populations is crucial to avoid misclassification of cells. The detection of \"dim\" antigens, which are expressed at low levels, is a common challenge. A higher resolution value indicates a greater ability to resolve such dim populations from the background. Laboratory guidelines often consider a resolution or stain index value greater than $5$ to be acceptable and a value greater than $10$ to be very good. A value of $18.33$ signifies a very bright signal relative to the background noise, indicating a robust assay that is highly suitable for the reliable detection of both bright and dim antigens, a critical requirement for accurate diagnosis and classification of hematologic malignancies like Chronic Lymphocytic Leukemia (CLL).",
            "answer": "$$\\boxed{18.33}$$"
        },
        {
            "introduction": "Even a perfectly optimized assay can produce misleading results if the data is not properly cleaned. One of the most significant sources of artifacts in flow cytometry is the presence of dead cells, which can nonspecifically bind antibodies and create false-positive signals. This exercise presents a common diagnostic dilemma to illustrate why viability gating is not merely a technical step, but a non-negotiable requirement for ensuring diagnostic accuracy and avoiding a misinterpretation of aberrant antigen expression. ",
            "id": "5226103",
            "problem": "A laboratory is immunophenotyping a suspected B-cell Acute Lymphoblastic Leukemia (B-ALL) using Flow Cytometry (FC). The panel includes CD19, CD10, CD34, CD45, and CD7, with isotype controls measured in parallel. The technologist acquires $n = 10^5$ events from a bone marrow aspirate. Blasts are gated by low CD45 and intermediate side scatter (SSC), then analyzed for CD7 expression. Dead cell exclusion is not initially applied. A second acquisition is then performed with a fixable amine-reactive viability dye and dead cells excluded.\n\nFoundational base to use:\n- Antigen–antibody binding occurs via specific complementarity of paratopes to epitopes; nonspecific binding increases when membrane integrity is lost due to enhanced permeability and exposure of intracellular binding sites and charged macromolecules.\n- In FC, fluorescence intensity reflects the number of fluorochrome molecules associated with a cell; Median Fluorescence Intensity (MFI) across a population summarizes signal distribution.\n- Viability dyes (for example, 7-Aminoactinomycin D (7-AAD) or fixable amine-reactive dyes) preferentially label cells with compromised membranes because intracellular amines become accessible, allowing separation of live from dead events.\n- Laboratory positivity is defined by an MFI ratio to the isotype control threshold of $> 2.0$ for a marker in the blast gate, and separately by percent-positive cells of $> 20\\%$ above a fixed fluorescence threshold.\n\nObserved data for CD7 in the blast gate:\n- Without viability gating: CD7 MFI $= 287.5$, isotype MFI $= 125$, percent-positive $= 28\\%$.\n- With viability gating (dead excluded): CD7 MFI $= 150$, isotype MFI $= 100$, percent-positive $= 8\\%$.\n\nAdditional single-cell measurements show that the subset identified as dead (strong viability dye signal) has CD7 fluorescence much higher than live blasts, and the dead subset comprises approximately $p_d = 0.25$ of blast-gated events in the ungated acquisition.\n\nA junior analyst suggests that the apparent CD7 positivity without viability gating indicates true aberrant T-lineage marker expression and potential mixed phenotype acute leukemia, while the senior scientist insists that the CD7 signal is an artifact of nonspecific antibody binding to dead cells and must be excluded before interpretation.\n\nWhich option best justifies, from first principles and the provided observations, why dead cell exclusion is critical to avoid nonspecific antibody binding that can mimic aberrant antigen expression in leukemias?\n\nA. Compromised membrane integrity in dead cells increases permeability and exposes intracellular amines and charged macromolecules, promoting nonspecific uptake and retention of fluorochrome-conjugated antibodies and isotype controls. Because FC reports population MFIs and percent-positive based on thresholds, inclusion of a high-fluorescence dead subset (here $p_d = 0.25$) shifts the weighted signals above positivity criteria (MFI ratio $= 287.5/125 = 2.30$ and $28\\%$ positive), although live blasts remain below thresholds (MFI ratio $= 150/100 = 1.50$ and $8\\%$ positive). Viability gating removes this nonspecific contribution, restoring biologically valid assessment of antigen expression.\n\nB. FC compensation algorithms assume all cells are alive and therefore miscompute spectral spillover when dead cells are present; excluding dead cells is necessary to prevent mathematical divergence of spillover coefficients, which otherwise causes instrument saturation independent of antigen binding.\n\nC. Dead cells rapidly upregulate lineage-inappropriate antigens post-mortem due to stress-induced transcription, revealing true aberrant expression; excluding them prevents misclassification but is not essential for interpreting antibody specificity.\n\nD. Dead cells lower forward scatter ($FSC$), biasing size estimates; excluding them primarily corrects size gating and thus indirectly fixes antigen quantification, since fluorescence intensity is determined by cell size rather than antibody binding specificity.",
            "solution": "The problem statement is subjected to validation before proceeding to a solution.\n\n### Step 1: Extract Givens\n- **Context:** Immunophenotyping of suspected B-cell Acute Lymphoblastic Leukemia (B-ALL) via Flow Cytometry (FC).\n- **Sample:** Bone marrow aspirate with $n = 10^5$ events acquired.\n- **Antibody Panel:** CD19, CD10, CD34, CD45, CD7, and isotype controls.\n- **Gating:** Blasts are defined by low CD45 expression and intermediate side scatter (SSC).\n- **Foundational Principles:**\n    1.  Nonspecific antibody binding increases when cell membrane integrity is lost.\n    2.  Median Fluorescence Intensity (MFI) is a measure of signal distribution in a population.\n    3.  Viability dyes separate live from dead cells based on membrane integrity.\n    4.  Positivity Criteria: MFI ratio to isotype $> 2.0$, or percent-positive cells $> 20\\%$.\n- **Data for CD7 in the blast gate (Without Viability Gating):**\n    - CD7 MFI $= 287.5$\n    - Isotype MFI $= 125$\n    - Percent-positive CD7 $= 28\\%$\n- **Data for CD7 in the blast gate (With Viability Gating, dead cells excluded):**\n    - CD7 MFI $= 150$\n    - Isotype MFI $= 100$\n    - Percent-positive CD7 $= 8\\%$\n- **Additional Information:**\n    - The subset of dead cells has much higher CD7 fluorescence than live blasts.\n    - The proportion of dead cells within the blast gate is $p_d = 0.25$.\n- **Question:** Justify, from first principles and the data, why dead cell exclusion is critical to avoid artifacts from nonspecific antibody binding.\n\n### Step 2: Validate Using Extracted Givens\n- **Scientifically Grounded:** The problem is firmly rooted in the established principles of flow cytometry and clinical immunology. The phenomenon of increased nonspecific antibody binding to dead cells is a well-known artifact that necessitates the use of viability dyes. The markers, cell types, and data values presented are realistic for a diagnostic hematopathology scenario. The principles provided are correct.\n- **Well-Posed:** The problem provides a clear scenario, quantitative data, and a set of explicit principles. The question asks for a specific justification based on this information, which allows for a single, logical, and derivable conclusion. The problem is self-contained.\n- **Objective:** The problem statement is presented using precise, technical language. It describes a common laboratory discrepancy and asks for the scientific explanation, free of subjective or opinion-based content.\n\n### Step 3: Verdict and Action\nThe problem is valid. It is scientifically sound, well-posed, objective, and contains sufficient information to derive a unique solution and evaluate the provided options. The solution process will now proceed.\n\n### Principle-Based Derivation\nThe core task is to determine why the initial observation of CD7 positivity on the blast population is reversed after excluding dead cells. We will use the provided data and principles to evaluate the two conditions.\n\n**Condition 1: Without Viability Gating**\nThe total population within the blast gate consists of both live and dead cells.\n- The MFI ratio for CD7 relative to its isotype control is calculated as:\n$$ \\text{MFI Ratio} = \\frac{\\text{CD7 MFI}}{\\text{Isotype MFI}} = \\frac{287.5}{125} = 2.30 $$\n- The percentage of cells positive for CD7 is given as $28\\%$.\n- According to the positivity criteria (MFI ratio $> 2.0$ or percent-positive $> 20\\%$), the blast population appears to be positive for CD7, as both criteria are met ($2.30 > 2.0$ and $28\\% > 20\\%$). This would suggest aberrant T-lineage marker expression, potentially indicating a mixed phenotype acute leukemia.\n\n**Condition 2: With Viability Gating (Live Cells Only)**\nAfter excluding dead cells, the analysis is restricted to the live blast population.\n- The MFI ratio for CD7 relative to its isotype control is now:\n$$ \\text{MFI Ratio} = \\frac{\\text{CD7 MFI}}{\\text{Isotype MFI}} = \\frac{150}{100} = 1.50 $$\n- The percentage of cells positive for CD7 is given as $8\\%$.\n- According to the positivity criteria, the live blast population is negative for CD7, as neither criterion is met ($1.50 \\ngtr 2.0$ and $8\\% \\ngtr 20\\%$).\n\n**Reconciling the Discrepancy**\nThe foundational principles state that loss of membrane integrity in dead cells leads to increased nonspecific binding. The data fully support this principle. The total MFI of a mixed population is a weighted average of the MFIs of its subpopulations. Let the subscripts 'total', 'live', and 'dead' denote the entire population, the live subset, and the dead subset, respectively. The proportion of dead cells is $p_d = 0.25$, so the proportion of live cells is $p_{live} = 1 - p_d = 0.75$.\n\nThe total MFI can be approximated as:\n$$ MFI_{total} \\approx (p_{live} \\cdot MFI_{live}) + (p_d \\cdot MFI_{dead}) $$\nFor the CD7 antibody:\n$$ 287.5 \\approx (0.75 \\cdot 150) + (0.25 \\cdot MFI_{dead, CD7}) $$\n$$ 287.5 \\approx 112.5 + (0.25 \\cdot MFI_{dead, CD7}) $$\n$$ 175 \\approx 0.25 \\cdot MFI_{dead, CD7} \\implies MFI_{dead, CD7} \\approx 700 $$\nFor the isotype control:\n$$ 125 \\approx (0.75 \\cdot 100) + (0.25 \\cdot MFI_{dead, Isotype}) $$\n$$ 125 \\approx 75 + (0.25 \\cdot MFI_{dead, Isotype}) $$\n$$ 50 \\approx 0.25 \\cdot MFI_{dead, Isotype} \\implies MFI_{dead, Isotype} \\approx 200 $$\n\nThese calculations confirm that the dead cell subset must have significantly higher fluorescence for both the specific antibody ($MFI \\approx 700$) and the isotype control ($MFI \\approx 200$) compared to the live cells (CD7 MFI $= 150$, Isotype MFI $= 100$). The high signal from the isotype control on dead cells is the definitive hallmark of nonspecific binding. This nonspecific binding is due to the compromised membranes of dead cells, which allows antibodies to enter and bind to intracellular structures and charged macromolecules, as stated in the principles.\n\nThe inclusion of this highly fluorescent, but nonspecifically stained, dead cell population ($25\\%$ of events) artificially inflates the overall MFI and percent-positive values for the entire gate, leading to a false-positive interpretation. By using a viability dye to exclude these dead cells, the analysis is confined to the live cells, revealing their true, biologically relevant immunophenotype, which in this case is negative for CD7. This invalidates the junior analyst's hypothesis and supports the senior scientist's insistence on excluding the artifact.\n\n### Option-by-Option Analysis\n**A. Compromised membrane integrity in dead cells increases permeability and exposes intracellular amines and charged macromolecules, promoting nonspecific uptake and retention of fluorochrome-conjugated antibodies and isotype controls. Because FC reports population MFIs and percent-positive based on thresholds, inclusion of a high-fluorescence dead subset (here $p_d = 0.25$) shifts the weighted signals above positivity criteria (MFI ratio $= 287.5/125 = 2.30$ and $28\\%$ positive), although live blasts remain below thresholds (MFI ratio $= 150/100 = 1.50$ and $8\\%$ positive). Viability gating removes this nonspecific contribution, restoring biologically valid assessment of antigen expression.**\nThis option perfectly aligns with the provided principles and the quantitative analysis derived from the data. It correctly identifies nonspecific binding due to membrane permeability as the cause, accurately uses the data to show how the dead cell subset skews the results to create a false positive, and correctly concludes that viability gating is essential to remove this artifact.\n**Verdict: Correct**\n\n**B. FC compensation algorithms assume all cells are alive and therefore miscompute spectral spillover when dead cells are present; excluding dead cells is necessary to prevent mathematical divergence of spillover coefficients, which otherwise causes instrument saturation independent of antigen binding.**\nThis option is incorrect. The primary artifact described is nonspecific binding, not an error in fluorescence compensation. Compensation corrects for spectral overlap between different fluorochromes, which is not the central issue here. While dead cells can have different autofluorescence spectra, this does not cause compensation coefficients to \"diverge,\" nor is it the direct cause of the false positivity observed for a single marker. The problem is the amount of antibody bound, not its spectral properties.\n**Verdict: Incorrect**\n\n**C. Dead cells rapidly upregulate lineage-inappropriate antigens post-mortem due to stress-induced transcription, revealing true aberrant expression; excluding them prevents misclassification but is not essential for interpreting antibody specificity.**\nThis option is biologically false. Cell death involves the cessation of active cellular processes like transcription and translation. Dead cells cannot \"upregulate\" antigens. The increased fluorescence is due to passive, nonspecific uptake of antibodies through a leaky membrane. Therefore, the observed signal is not \"true aberrant expression,\" and excluding these cells is absolutely essential for correct interpretation.\n**Verdict: Incorrect**\n\n**D. Dead cells lower forward scatter ($FSC$), biasing size estimates; excluding them primarily corrects size gating and thus indirectly fixes antigen quantification, since fluorescence intensity is determined by cell size rather than antibody binding specificity.**\nThis option misidentifies the root cause and contains a fundamentally incorrect premise. While dead cells often have altered light scatter properties (FSC and SSC), the primary reason for excluding them is their compromised membrane integrity leading to nonspecific binding, not their size. The statement that \"fluorescence intensity is determined by cell size rather than antibody binding specificity\" is false. In immunophenotyping, fluorescence intensity is primarily a function of the number of specifically bound antibodies, which reflects the antigen expression level.\n**Verdict: Incorrect**",
            "answer": "$$\\boxed{A}$$"
        },
        {
            "introduction": "With clean data from a high-quality assay, we can proceed to diagnostic interpretation. A fundamental question in evaluating B-cell populations is determining clonality—whether the cells originate from a single malignant precursor. This hands-on practice guides you through calculating the kappa/lambda light chain ratio, a key indicator of clonality, and importantly, using statistical principles to construct a confidence interval, allowing you to assess the strength of your evidence and make a conclusion with statistical rigor. ",
            "id": "5226106",
            "problem": "A flow cytometry immunophenotyping study of B-lymphocytes gated on cluster of differentiation 19 positive (CD19+) events is performed to assess light chain restriction as part of laboratory diagnostics for suspected clonal lymphoproliferative disease. Among the CD19+ gate, there are $800$ events positive for kappa light chain and $100$ events positive for lambda light chain. Assume that within this gate every event expresses exactly one light chain (no double-positives or double-negatives) and that each event can be modeled as an independent Bernoulli trial for “kappa” versus “lambda” assignment.\n\nStarting from the binomial model and the Central Limit Theorem, define the observed kappa proportion $ \\hat{p} $ and its sampling variability, derive an approximate two-sided $95\\%$ Confidence Interval (CI) for the true kappa proportion $p$, and then use the monotonic transformation $R = \\frac{p}{1-p}$ to obtain an approximate $95\\%$ CI for the true kappa-to-lambda ratio $R$. Interpret whether the B-cell population is likely clonal, using as a well-tested reference that polyclonal surface immunoglobulin light chain ratios in reactive samples typically fall within $0.5$ to $3.0$.\n\nReport the kappa-to-lambda ratio computed from the observed counts as your final numeric answer. Round this ratio to three significant figures. Express the final ratio as a pure number with no units.",
            "solution": "The problem statement is evaluated as valid. It is scientifically grounded in the principles of laboratory diagnostics (immunophenotyping) and biostatistics (binomial model, Central Limit Theorem, confidence intervals). The problem is well-posed, providing all necessary data and a clear, objective question. The given values and reference ranges are realistic within the clinical context.\n\nLet $n_k$ be the number of observed events positive for the kappa light chain and $n_l$ be the number of observed events positive for the lambda light chain.\nFrom the problem statement, we are given:\n$n_k = 800$\n$n_l = 100$\n\nThe total number of B-lymphocyte events, $N$, within the CD19+ gate is the sum of kappa and lambda positive events, as it is stated that every event expresses exactly one light chain.\n$$N = n_k + n_l = 800 + 100 = 900$$\n\nLet $p$ be the true proportion of kappa-positive cells in the underlying B-cell population. Each cell is considered an independent Bernoulli trial with a probability $p$ of being kappa-positive and a probability $1-p$ of being lambda-positive. The number of kappa-positive cells, $X_k$, in a sample of size $N$ follows a binomial distribution, $X_k \\sim \\text{Binomial}(N, p)$.\n\nThe observed proportion of kappa-positive cells, $\\hat{p}$, is the point estimate for $p$:\n$$\\hat{p} = \\frac{n_k}{N} = \\frac{800}{900} = \\frac{8}{9}$$\n\nAccording to the Central Limit Theorem, for a large sample size $N$ (here $N=900$, which is sufficiently large), the sampling distribution of the sample proportion $\\hat{p}$ can be approximated by a normal distribution:\n$$\\hat{p} \\approx \\mathcal{N}\\left(p, \\frac{p(1-p)}{N}\\right)$$\nThe standard error of the proportion, $SE(\\hat{p})$, is given by $\\sqrt{\\frac{p(1-p)}{N}}$. For the purpose of constructing a confidence interval, we approximate the standard error by substituting the sample proportion $\\hat{p}$ for the true proportion $p$:\n$$SE(\\hat{p}) \\approx \\sqrt{\\frac{\\hat{p}(1-\\hat{p})}{N}} = \\sqrt{\\frac{(\\frac{8}{9})(1 - \\frac{8}{9})}{900}} = \\sqrt{\\frac{(\\frac{8}{9})(\\frac{1}{9})}{900}} = \\sqrt{\\frac{8}{81 \\times 900}} = \\frac{\\sqrt{8}}{9 \\times 30} = \\frac{2\\sqrt{2}}{270} = \\frac{\\sqrt{2}}{135}$$\n\nAn approximate two-sided $95\\%$ confidence interval (CI) for the true proportion $p$ is given by the formula:\n$$\\text{CI}_p = \\hat{p} \\pm z_{\\alpha/2} \\cdot SE(\\hat{p})$$\nFor a $95\\%$ CI, the significance level is $\\alpha = 0.05$, so $\\alpha/2 = 0.025$. The corresponding critical value from the standard normal distribution is $z_{0.025} \\approx 1.96$.\nThe $95\\%$ CI for $p$ is:\n$$\\text{CI}_p = \\left[ \\frac{8}{9} - 1.96 \\frac{\\sqrt{2}}{135}, \\frac{8}{9} + 1.96 \\frac{\\sqrt{2}}{135} \\right]$$\nNumerically, the interval is approximately:\n$$p_{lower} \\approx 0.8889 - 1.96 \\left(\\frac{1.4142}{135}\\right) \\approx 0.8889 - 0.0205 = 0.8684$$\n$$p_{upper} \\approx 0.8889 + 1.96 \\left(\\frac{1.4142}{135}\\right) \\approx 0.8889 + 0.0205 = 0.9094$$\nSo, $\\text{CI}_p \\approx [0.8684, 0.9094]$.\n\nThe problem requires a $95\\%$ CI for the true kappa-to-lambda ratio, $R = \\frac{p}{1-p}$. The function $f(p) = \\frac{p}{1-p}$ is monotonically increasing for $p \\in (0,1)$. Therefore, we can obtain the CI for $R$ by applying this transformation to the endpoints of the CI for $p$.\nThe lower bound for $R$ is:\n$$R_{lower} = \\frac{p_{lower}}{1-p_{lower}} \\approx \\frac{0.8684}{1-0.8684} = \\frac{0.8684}{0.1316} \\approx 6.5988$$\nThe upper bound for $R$ is:\n$$R_{upper} = \\frac{p_{upper}}{1-p_{upper}} \\approx \\frac{0.9094}{1-0.9094} = \\frac{0.9094}{0.0906} \\approx 10.0375$$\nThus, the approximate $95\\%$ CI for the true kappa-to-lambda ratio $R$ is $[6.60, 10.04]$.\n\nTo interpret this result, we compare the CI to the reference range for polyclonal B-cell populations, which is given as $0.5$ to $3.0$. The calculated $95\\%$ confidence interval for the true ratio, $[6.60, 10.04]$, lies entirely outside and above this reference range. This indicates with high confidence that the true ratio is abnormal. Such a marked elevation and restriction to one light chain type (kappa) is a hallmark of a clonal process, strongly suggesting a B-cell lymphoproliferative disorder.\n\nThe final task is to report the kappa-to-lambda ratio computed from the observed counts, rounded to three significant figures. This is the sample ratio, $\\hat{R}$.\n$$\\hat{R} = \\frac{n_k}{n_l} = \\frac{800}{100} = 8$$\nTo express this value with three significant figures, we write it as $8.00$.",
            "answer": "$$\\boxed{8.00}$$"
        }
    ]
}